BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 5835110)

  • 1. Role of the regional lymph nodes in chemically-induced tumor immunity.
    Bard DS; Hammond WG; Ketcham AS
    Surg Forum; 1965; 16():110-1. PubMed ID: 5835110
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on transplantation immunity of methylcholanthrene-induced tumor by use of transplantation in lymph nodes and of diffusion chamber.
    Kitano M; Okada Y; Nagaishi C
    Exp Med Surg; 1969; 27(4):357-83. PubMed ID: 5384538
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of regional lymphadenectomy on development of concomitant immunity.
    Soloway MS; Pendergrast WJ; Myers GH
    Surg Forum; 1972; 23(0):101-2. PubMed ID: 4671039
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro studies on the inhibitory effect of lymph-node cells. I. Antitumor activity of regional lymph-node cells from methylcholanthrene-induced sarcoma bearing mice on the same primary culture sarcoma cells.
    Osugi M
    Acta Med Okayama (1952); 1970 Aug; 24(4):447-56. PubMed ID: 4254199
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibitory effect of isologous regional lymphnode cells from the methylcholanthrene-induced sarcoma bearing mice on the tumor in vivo.
    Kashihara E
    Acta Med Okayama (1952); 1970 Apr; 24(2):161-73. PubMed ID: 4247892
    [No Abstract]   [Full Text] [Related]  

  • 6. Histological modifications of the lymph nodes in mice bearing syngeneic grafts of tumours induced by methylcholanthrene.
    Simar LJ; Focan C; Boniver J; Betz EH
    Pathol Eur; 1975; 10(4):317-25. PubMed ID: 1208123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of methylcholanthrene-induced tumors tested by draining lymph node assay in syngeneic rats.
    Ryzewska AG; Rybicka M; Kania A; Dabrowski M
    Neoplasma; 1980; 27(5):533-42. PubMed ID: 7231610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional lymphadenectomy and tumor immunity.
    Pendergrast WJ; Soloway MS; Myers GH; Futrell JW
    Surg Gynecol Obstet; 1976 Mar; 142(3):385-90. PubMed ID: 1251321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment and immunologic characterization of 3-methylcholanthrene-induced sarcoma cell lines metastasizing widely in mice and exhibiting distinct and selective propensities for the mode of metastasis.
    Kodama Y; Seyama T; Kamiya K; Yokoro K
    J Natl Cancer Inst; 1982 Sep; 69(3):595-605. PubMed ID: 7050499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of different doses of cyclophosphamide on the immune response of mice with a methylcholanthrene-induced sarcoma].
    Gordienko SP; Bergol'ts VM
    Vopr Onkol; 1973; 19(11):54-60. PubMed ID: 4785975
    [No Abstract]   [Full Text] [Related]  

  • 11. Cellular reactions to methylcholanthrene-induced sarcomas transplanted to isogenic mice.
    Rosenau W; Moon HD
    Lab Invest; 1966 Jul; 15(7):1212-24. PubMed ID: 5947068
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of metastasis in rats immunized with xenogenized autologous tumor cells after excision of the primary tumor.
    Kobayashi H; Gotohda E; Hosokawa M; Kodama T
    J Natl Cancer Inst; 1975 Apr; 54(4):997-9. PubMed ID: 1127731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Proceedings: Effect of lymphadenectomy on neoplasm immunity].
    Oikawa K; Kodama T; Kobayaschi H
    Hokkaido Igaku Zasshi; 1975 Jan; 50(1):84-5. PubMed ID: 1171069
    [No Abstract]   [Full Text] [Related]  

  • 14. [Concentration of theta-plus-lymphocytes in the regional and distant lymph nodes C3H/Sn strain mice during development of primary methylcholanthrene sarcomas].
    Iudin VM; Fedorovskaia MI; Umanskiĭ IuA
    Biull Eksp Biol Med; 1975 Jan; 79(1):57-9. PubMed ID: 1078631
    [No Abstract]   [Full Text] [Related]  

  • 15. Morphologic studies of lymphoid tissues during the growth of an isotransplanted mouse tumor.
    Krüger G
    J Natl Cancer Inst; 1967 Jul; 39(1):1-15. PubMed ID: 6028286
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of blocking antibodies in immunological enhancement.
    Takasugi M; Klein E
    Immunology; 1971 Oct; 21(4):675-84. PubMed ID: 5121758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of the immune response to antigenic tumors in isogenic mice by whole-body irradiation.
    Rosenau W; Moon HD
    Cancer Res; 1967 Nov; 27(11):1973-81. PubMed ID: 6073496
    [No Abstract]   [Full Text] [Related]  

  • 18. Ribonucleic acid-mediated inhibition and enhancement of tumor growth in mice.
    Ramming KP; Pilch YH
    Surg Forum; 1969; 20():106-9. PubMed ID: 5383020
    [No Abstract]   [Full Text] [Related]  

  • 19. Tumor inhibition by means of sensitized regional lymph nodes.
    Arlen M; Forte RA; Levowitz BS; Scherrer J; Hodenberg M
    Surg Forum; 1969; 20():114-5. PubMed ID: 5383023
    [No Abstract]   [Full Text] [Related]  

  • 20. Properties of a M(r) 110,000 tumor rejection antigen of the chemically induced BALB/c Meth A sarcoma.
    De Leo AB; Becker M; Lu L; Law LW
    Cancer Res; 1993 Apr; 53(7):1602-7. PubMed ID: 7680955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.